SLC30A7 has anti-oxidant stress effects in high glucose-induced apoptosis via the NFE2L2/HMOX1 signal transduction pathway
Related Experiment Video
Updated: Dec 8, 2025
Xiuli Zhang1, Tingwen Guan2, Boxuan Yang2
1Department of Nephrology, Second People's Hospital, The First Affiliated Hospital of Shenzhen University, Shenzhen, Guangdong Province 518000, PR China; Department of Pathophysiology, China Medical University, Shenyang, Liaoning Province 110001, PR China.
Aims:
Apoptosis and oxidant stress are known to be involved in the pathogenesis of diabetic kidney disease (DKD). We have previously reported that zinc transporter 7 in SLC30 family (SLC30A7) inhibits apoptosis in rat peritoneal mesothelial cells under high glucose (HG) conditions. In the current study, we aimed to investigate whether SLC30A7 had effect for anti-oxidant stress in renal tubular epithelial cells under HG.
Methods:
SLC30A7 in HG-induced apoptosis in a normal rat kidney tubular epithelial cell line (NRK-52E cells)/kidneys of STZ-induced diabetic mice was examined and the activity of nuclear factor erythroid 2-related factor 2 (NFE2L2) was further analyzed by using real time RT-PCR, siRNA and Western blot protocols.
Results:
SLC30A7 was found to be up-regulated, while NFE2L2 was activated in kidneys of STZ-induced diabetic mice and HG-induced apoptosis of NRK-52E cells. Knock-down of SLC30A7 with siRNA protocol resulted in lower intracellular free zinc levels in the cells and decreased zinc distribution in the Golgi apparatus. Furthermore, knock-down of NFE2L2 down-regulated its target HMOX1 gene expression, decreased SLC30A7 activity but increased HG-induced apoptosis.
Conclusion:
The current study provides new evidence that SLC30A7 has anti-oxidant stress effects in HG-induced apoptosis via the NFE2L2/HMOX1 signal transduction pathway.
Insights
Zinc transporter 7 (SLC30A7) protects kidney cells from high glucose-induced apoptosis by reducing oxidative stress. This occurs through the nuclear factor erythroid 2-related factor 2 (NFE2L2)/HMOX1 pathway, offering a potential therapeutic target for diabetic kidney disease.
Area of Science:
- Cell Biology
- Renal Physiology
- Molecular Medicine
Background:
- Diabetic kidney disease (DKD) pathogenesis involves apoptosis and oxidative stress.
- Previous work identified SLC30A7 as an inhibitor of apoptosis in mesothelial cells under high glucose (HG).
Purpose of the Study:
- To investigate the anti-oxidant stress effects of SLC30A7 in renal tubular epithelial cells under HG conditions.
Main Methods:
- Examined SLC30A7 in HG-induced apoptosis in NRK-52E cells and STZ-induced diabetic mouse kidneys.
- Analyzed nuclear factor erythroid 2-related factor 2 (NFE2L2) activity using RT-PCR, siRNA, and Western blot.
Main Results:
- SLC30A7 was upregulated, and NFE2L2 activated in diabetic kidneys and HG-treated cells.
- SLC30A7 knockdown reduced intracellular zinc and Golgi distribution, increasing HG-induced apoptosis.
- NFE2L2 knockdown decreased HMOX1 expression and SLC30A7 activity, exacerbating apoptosis.
Conclusions:
- SLC30A7 exhibits anti-oxidant stress effects against HG-induced apoptosis.
- These effects are mediated through the NFE2L2/HMOX1 signal transduction pathway.


